カテゴリ： 世界, 医療/バイオ, QYResearch

帯状疱疹後神経痛治療の世界市場2023年：抗けいれん薬、貼付剤、その他

■ 英語タイトル：Global Post herpetic Neuralgia Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8275）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8275
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[帯状疱疹後神経痛治療の世界市場2023年：抗けいれん薬、貼付剤、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は帯状疱疹後神経痛治療のグローバル市場について調査・分析し、世界の帯状疱疹後神経痛治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（抗けいれん薬、貼付剤、その他）、用途別セグメント分析（病院薬局、オンライン薬局、小売薬局）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer、Arbor Pharma、Assertio Therapeutics、Endo Pharma、Teikoku Pharma、Teva、Mylan、Hengrui Medicineなどが含まれています。帯状疱疹後神経痛治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、帯状疱疹後神経痛治療市場規模を算出する際に考慮しました。

・帯状疱疹後神経痛治療市場の概要
- 帯状疱疹後神経痛治療の種類別セグメント
- 世界の帯状疱疹後神経痛治療市場規模：タイプ別分析（抗けいれん薬、貼付剤、その他）
- 帯状疱疹後神経痛治療の用途別セグメント
- 世界の帯状疱疹後神経痛治療市場規模：用途別分析（病院薬局、オンライン薬局、小売薬局）
- 世界の帯状疱疹後神経痛治療市場規模予測（2018年-2029年）

・帯状疱疹後神経痛治療市場の成長トレンド
- 帯状疱疹後神経痛治療の地域別市場規模（2018年-2029年）
- 帯状疱疹後神経痛治療市場ダイナミクス
- 帯状疱疹後神経痛治療の業界動向
- 帯状疱疹後神経痛治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：抗けいれん薬、貼付剤、その他
- 世界の帯状疱疹後神経痛治療のタイプ別市場規模（2018年-2023年）
- 世界の帯状疱疹後神経痛治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、オンライン薬局、小売薬局
- 世界の帯状疱疹後神経痛治療の用途別市場規模（2018年-2023年）
- 世界の帯状疱疹後神経痛治療の用途別市場規模（2024年-2029年）

・帯状疱疹後神経痛治療の地域別市場規模
- 北米の帯状疱疹後神経痛治療市場規模（2018年-2029年）
- 米国の帯状疱疹後神経痛治療市場規模（2018年-2029年）
- ヨーロッパの帯状疱疹後神経痛治療市場規模（2018年-2029年）
- アジア太平洋の帯状疱疹後神経痛治療市場規模（2018年-2029年）
- 中国の帯状疱疹後神経痛治療市場規模（2018年-2029年）
- 日本の帯状疱疹後神経痛治療市場規模（2018年-2029年）
- 韓国の帯状疱疹後神経痛治療市場規模（2018年-2029年）
- インドの帯状疱疹後神経痛治療市場規模（2018年-2029年）
- オーストラリアの帯状疱疹後神経痛治療市場規模（2018年-2029年）
- 中南米の帯状疱疹後神経痛治療市場規模（2018年-2029年）
- 中東・アフリカの帯状疱疹後神経痛治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer、Arbor Pharma、Assertio Therapeutics、Endo Pharma、Teikoku Pharma、Teva、Mylan、Hengrui Medicine

・アナリストの観点/結論

・調査手法と情報源

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Highlights
The global Post herpetic Neuralgia Treatment market was valued at US$ 1654.8 million in 2022 and is anticipated to reach US$ 2093.9 million by 2029, witnessing a CAGR of 4.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.
The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Post herpetic Neuralgia Treatment market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post herpetic Neuralgia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by distribution channel, and by regions.
By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Segment by Type
Anticonvulsants
Skin Patch
Other
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, distribution channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post herpetic Neuralgia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Anticonvulsants
1.2.3 Skin Patch
1.2.4 Other
1.3 Market by Distribution Channel
1.3.1 Global Post herpetic Neuralgia Treatment Market Growth by Distribution Channel: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post herpetic Neuralgia Treatment Market Perspective (2018-2029)
2.2 Post herpetic Neuralgia Treatment Growth Trends by Region
2.2.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Post herpetic Neuralgia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Post herpetic Neuralgia Treatment Forecasted Market Size by Region (2024-2029)
2.3 Post herpetic Neuralgia Treatment Market Dynamics
2.3.1 Post herpetic Neuralgia Treatment Industry Trends
2.3.2 Post herpetic Neuralgia Treatment Market Drivers
2.3.3 Post herpetic Neuralgia Treatment Market Challenges
2.3.4 Post herpetic Neuralgia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue
3.1.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue (2018-2023)
3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post herpetic Neuralgia Treatment Revenue
3.4 Global Post herpetic Neuralgia Treatment Market Concentration Ratio
3.4.1 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post herpetic Neuralgia Treatment Revenue in 2022
3.5 Post herpetic Neuralgia Treatment Key Players Head office and Area Served
3.6 Key Players Post herpetic Neuralgia Treatment Product Solution and Service
3.7 Date of Enter into Post herpetic Neuralgia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post herpetic Neuralgia Treatment Breakdown Data by Type
4.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2024-2029)
5 Post herpetic Neuralgia Treatment Breakdown Data by Distribution Channel
5.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Distribution Channel (2018-2023)
5.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2024-2029)
6 North America
6.1 North America Post herpetic Neuralgia Treatment Market Size (2018-2029)
6.2 North America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Post herpetic Neuralgia Treatment Market Size by Country (2018-2023)
6.4 North America Post herpetic Neuralgia Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post herpetic Neuralgia Treatment Market Size (2018-2029)
7.2 Europe Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Post herpetic Neuralgia Treatment Market Size by Country (2018-2023)
7.4 Europe Post herpetic Neuralgia Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size (2018-2029)
8.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post herpetic Neuralgia Treatment Market Size (2018-2029)
9.2 Latin America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2018-2023)
9.4 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2018-2029)
10.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Post herpetic Neuralgia Treatment Introduction
11.1.4 Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Arbor Pharma
11.2.1 Arbor Pharma Company Detail
11.2.2 Arbor Pharma Business Overview
11.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Introduction
11.2.4 Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.2.5 Arbor Pharma Recent Development
11.3 Assertio Therapeutics
11.3.1 Assertio Therapeutics Company Detail
11.3.2 Assertio Therapeutics Business Overview
11.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Introduction
11.3.4 Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.3.5 Assertio Therapeutics Recent Development
11.4 Endo Pharma
11.4.1 Endo Pharma Company Detail
11.4.2 Endo Pharma Business Overview
11.4.3 Endo Pharma Post herpetic Neuralgia Treatment Introduction
11.4.4 Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.4.5 Endo Pharma Recent Development
11.5 Teikoku Pharma
11.5.1 Teikoku Pharma Company Detail
11.5.2 Teikoku Pharma Business Overview
11.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Introduction
11.5.4 Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.5.5 Teikoku Pharma Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Post herpetic Neuralgia Treatment Introduction
11.6.4 Teva Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.6.5 Teva Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Post herpetic Neuralgia Treatment Introduction
11.7.4 Mylan Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.7.5 Mylan Recent Development
11.8 Hengrui Medicine
11.8.1 Hengrui Medicine Company Detail
11.8.2 Hengrui Medicine Business Overview
11.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Introduction
11.8.4 Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2018-2023)
11.8.5 Hengrui Medicine Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Anticonvulsants
Table 3. Key Players of Skin Patch
Table 4. Key Players of Other
Table 5. Global Post herpetic Neuralgia Treatment Market Size Growth by Distribution Channel (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Post herpetic Neuralgia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Post herpetic Neuralgia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Post herpetic Neuralgia Treatment Market Share by Region (2018-2023)
Table 9. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Post herpetic Neuralgia Treatment Market Share by Region (2024-2029)
Table 11. Post herpetic Neuralgia Treatment Market Trends
Table 12. Post herpetic Neuralgia Treatment Market Drivers
Table 13. Post herpetic Neuralgia Treatment Market Challenges
Table 14. Post herpetic Neuralgia Treatment Market Restraints
Table 15. Global Post herpetic Neuralgia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Post herpetic Neuralgia Treatment Market Share by Players (2018-2023)
Table 17. Global Top Post herpetic Neuralgia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2022)
Table 18. Ranking of Global Top Post herpetic Neuralgia Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Post herpetic Neuralgia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Post herpetic Neuralgia Treatment Product Solution and Service
Table 22. Date of Enter into Post herpetic Neuralgia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post herpetic Neuralgia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 29. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2018-2023)
Table 30. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 31. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2024-2029)
Table 32. North America Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Post herpetic Neuralgia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Post herpetic Neuralgia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Post herpetic Neuralgia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Post herpetic Neuralgia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Post herpetic Neuralgia Treatment Product
Table 50. Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Arbor Pharma Company Detail
Table 53. Arbor Pharma Business Overview
Table 54. Arbor Pharma Post herpetic Neuralgia Treatment Product
Table 55. Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 56. Arbor Pharma Recent Development
Table 57. Assertio Therapeutics Company Detail
Table 58. Assertio Therapeutics Business Overview
Table 59. Assertio Therapeutics Post herpetic Neuralgia Treatment Product
Table 60. Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 61. Assertio Therapeutics Recent Development
Table 62. Endo Pharma Company Detail
Table 63. Endo Pharma Business Overview
Table 64. Endo Pharma Post herpetic Neuralgia Treatment Product
Table 65. Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 66. Endo Pharma Recent Development
Table 67. Teikoku Pharma Company Detail
Table 68. Teikoku Pharma Business Overview
Table 69. Teikoku Pharma Post herpetic Neuralgia Treatment Product
Table 70. Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 71. Teikoku Pharma Recent Development
Table 72. Teva Company Detail
Table 73. Teva Business Overview
Table 74. Teva Post herpetic Neuralgia Treatment Product
Table 75. Teva Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 76. Teva Recent Development
Table 77. Mylan Company Detail
Table 78. Mylan Business Overview
Table 79. Mylan Post herpetic Neuralgia Treatment Product
Table 80. Mylan Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Hengrui Medicine Company Detail
Table 83. Hengrui Medicine Business Overview
Table 84. Hengrui Medicine Post herpetic Neuralgia Treatment Product
Table 85. Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2018-2023) & (US$ Million)
Table 86. Hengrui Medicine Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post herpetic Neuralgia Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Post herpetic Neuralgia Treatment Market Share by Type: 2022 VS 2029
Figure 3. Anticonvulsants Features
Figure 4. Skin Patch Features
Figure 5. Other Features
Figure 6. Global Post herpetic Neuralgia Treatment Market Size Comparison by Distribution Channel (2023-2029) & (US$ Million)
Figure 7. Global Post herpetic Neuralgia Treatment Market Share by Distribution Channel: 2022 VS 2029
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Post herpetic Neuralgia Treatment Report Years Considered
Figure 12. Global Post herpetic Neuralgia Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Post herpetic Neuralgia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Post herpetic Neuralgia Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Post herpetic Neuralgia Treatment Market Share by Players in 2022
Figure 16. Global Top Post herpetic Neuralgia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Post herpetic Neuralgia Treatment Revenue in 2022
Figure 18. North America Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Post herpetic Neuralgia Treatment Market Share by Country (2018-2029)
Figure 20. United States Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Post herpetic Neuralgia Treatment Market Share by Country (2018-2029)
Figure 24. Germany Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Region (2018-2029)
Figure 32. China Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Post herpetic Neuralgia Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Post herpetic Neuralgia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 47. Arbor Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 48. Assertio Therapeutics Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 49. Endo Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 50. Teikoku Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 52. Mylan Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 53. Hengrui Medicine Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 帯状疱疹後神経痛治療薬のグローバル市場展望 2023年-2029年：抗けいれん薬、抗うつ薬、オピオイド、その他
  • セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法
  • ネザートン症候群治療の世界市場2023年：放射線治療、生物治療、その他
  • 薬剤耐性結核治療薬の世界市場2023年：第一類抗結核薬、第二類抗結核薬、その他
  • 体部白癬治療の世界市場2023年：局所、経口
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8275 )"帯状疱疹後神経痛治療の世界市場2023年：抗けいれん薬、貼付剤、その他" (英文：Global Post herpetic Neuralgia Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。